Skip to main content
Fig. 4 | Autoimmunity Highlights

Fig. 4

From: Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases

Fig. 4

Receiver-operating characteristics curve analysis of anti-phospholipid antibodies (aPL) detected by enzyme-linked immunosorbent assay (ELISA) and line immunoassay (LIA) in 34 patients with anti-phospholipid syndrome and 41 disease controls without clinical APS symptoms. The ratio of anti-domain 1 (aD1) and D4–5 antibody reactivity (aD4–5) by ELISA was compared with criteria aPL determined by ELISA (a) and aPL IgG by LIA (b). aβ2GPI anti-beta2-glycoprotein I, aCL anti-cardiolipin, aPG anti-phosphatidylglycerol, aPI anti-phosphatidylinositol, aPS anti-phosphatidylserine, aPT anti-prothrombin

Back to article page

Autoimmunity Highlights

ISSN: 2038-3274

Contact us